Sorriso Pharmaceuticals, Inc.
🇺🇸United States
A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Sorriso Pharmaceuticals, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06080048
- Locations
- 🇺🇦
Arensia Exploratory Medicine, Kyiv, Ukraine
© Copyright 2025. All Rights Reserved by MedPath